Biocon Biologics Reaches Landmark Sales Figure As IPO Beckons

Key
BIOCON CONTINUES TO INCH TOWARDS PLANS TO UNLOCK VALUE OF ITS BIOLOGICS BUSINESS • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

More from Business

More from Generics Bulletin